Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

The challenge of pain in the pharmacological management of Parkinson's disease.

Jost WH, Buhmann C.

Expert Opin Pharmacother. 2019 Jul 10:1-8. doi: 10.1080/14656566.2019.1639672. [Epub ahead of print]

PMID:
31290336
2.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jun 25. doi: 10.1007/s00702-019-02025-9. [Epub ahead of print] Review.

PMID:
31240402
3.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.

J Neural Transm (Vienna). 2019 Jun 20. doi: 10.1007/s00702-019-02034-8. [Epub ahead of print]

PMID:
31222604
4.

[Hypersalivation - Update of the S2k guideline (AWMF) in short form].

Steffen A, Jost W, Bäumer T, Beutner D, Degenkolb-Weyers S, Groß M, Grosheva M, Hakim S, Kahl KG, Laskawi R, Lencer R, Löhler J, Meyners T, Rohrbach-Volland S, Schönweiler R, Schröder SC, Schröder S, Schröter-Morasch H, Schuster M, Steinlechner S, Urban R, Guntinas-Lichius O.

Laryngorhinootologie. 2019 Jun;98(6):388-397. doi: 10.1055/a-0874-2406. Epub 2019 Jun 5. German.

PMID:
31167292
5.

Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.

J Neural Transm (Vienna). 2019 May 13. doi: 10.1007/s00702-019-02012-0. [Epub ahead of print] Review.

PMID:
31087195
6.

[S1-Guideline for Diagnosis and Treatment of Erectile Dysfunction].

Haensch CA, Hilz M, Jost W, Kaufmann A, Kessler T, Lahrmann H.

Fortschr Neurol Psychiatr. 2019 Apr;87(4):225-233. doi: 10.1055/a-0747-5892. Epub 2019 Apr 18. German.

PMID:
30999379
7.

Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Steffen A, Jost W, Bäumer T, Beutner D, Degenkolb-Weyers S, Groß M, Grosheva M, Hakim S, Kahl KG, Laskawi R, Lencer R, Löhler J, Meyners T, Rohrbach-Volland S, Schönweiler R, Schröder SC, Schröder S, Schröter-Morasch H, Schuster M, Steinlechner S, Urban R, Guntinas-Lichius O.

J Neural Transm (Vienna). 2019 Apr 10. doi: 10.1007/s00702-019-02000-4. [Epub ahead of print] Review.

PMID:
30972507
8.

[Therapy of Hemifacial Spasm with Botulinum Toxin].

Jost WH, Laskawi R, Palmowski-Wolfe A, Urban PP.

Laryngorhinootologie. 2019 Apr;98(4):247-251. doi: 10.1055/a-0834-4188. Epub 2019 Apr 9. German.

PMID:
30968378
9.

Time for a new definition of Parkinson's disease.

Jost WH, Reichmann H.

J Neural Transm (Vienna). 2019 Apr 5. doi: 10.1007/s00702-019-01999-w. [Epub ahead of print] No abstract available.

PMID:
30953163
10.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

11.

Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study.

Jost WH, Schramm A, Müngersdorf M, Stenner A, Schwingenschuh P, Maisonobe P, Koch M, Haslinger B.

J Neurol Sci. 2019 Apr 15;399:44-50. doi: 10.1016/j.jns.2019.02.017. Epub 2019 Feb 10.

12.

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, Müller T, Jost W, Ebersbach G, Gold R, Krogias C, Tönges L.

Cells. 2019 Feb 11;8(2). pii: E151. doi: 10.3390/cells8020151.

13.

Botulinumtoxin for bladder disorders.

Schulte-Baukloh H, Bauer R, Jost W, Wissel J, van Ophoven A.

Fortschr Neurol Psychiatr. 2019 Feb;87(1):23-30. doi: 10.1055/a-0599-0697. Epub 2018 Dec 3. German.

PMID:
30508871
14.

Bilateral Globus Pallidus Internus Deep Brain Stimulation in a Case of Progressive Dystonia in Mohr-Tranebjaerg Syndrome with Bilateral Cochlear Implants.

Coenen VA, Rijntjes M, Sajonz B, Piroth T, Prokop T, Jost W, Trippel M, Urbach H, Reinacher PC.

J Neurol Surg A Cent Eur Neurosurg. 2019 Jan;80(1):44-48. doi: 10.1055/s-0038-1669472. Epub 2018 Oct 5.

PMID:
30290379
15.

[Effectiveness and safety of safinamide as add-on to levodopa in patients with parkinson's disease: non-interventional study].

Jost WH, Kupsch A, Mengs J, Delf M, Bosse D.

Fortschr Neurol Psychiatr. 2018 Oct;86(10):624-634. doi: 10.1055/a-0665-4667. Epub 2018 Aug 24. German.

PMID:
30142650
16.

[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].

Antonini A, Jost WH.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S5-S9. doi: 10.1055/a-0646-4164. Epub 2018 Aug 14. Review. German.

PMID:
30107620
17.

[Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany : Analysis of 1.5 million patient cases from 2010 to 2015].

Tönges L, Bartig D, Muhlack S, Jost W, Gold R, Krogias C.

Nervenarzt. 2019 Feb;90(2):167-174. doi: 10.1007/s00115-018-0590-5. German.

PMID:
30083879
18.

[Treatment of end-of-dose fluctuations: the need for an individualized approach].

Lingor P, Claßen J, Herbst H, Storch A, Urban P, Wellach I, Jost WH.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S59-S62. doi: 10.1055/a-0583-8460. Epub 2018 Jul 18. Review. German.

PMID:
30021233
19.

OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.

Wein T, Esquenazi A, Jost WH, Ward AB, Pan G, Dimitrova R.

PM R. 2018 Jul;10(7):693-703. doi: 10.1016/j.pmrj.2017.12.006. Epub 2018 Jan 9.

PMID:
29330071
20.

Nurse-driven analgesia and sedation in pediatric patients with univentricular hearts requiring extracorporeal life support after first-stage palliation surgery: A pilot study.

Michel J, Hofbeck M, Gerbig I, Icheva V, Heimberg E, Jost W, Schlensak C, Kumpf M, Blumenstock G, Neunhoeffer F.

Paediatr Anaesth. 2017 Dec;27(12):1261-1270. doi: 10.1111/pan.13274. Epub 2017 Oct 24.

PMID:
29063727
21.

[Practical use of continuous apomorphine infusion via pump].

Tönges L, Ceballos-Baumann A, Honig H, Storch A, Jost WH.

Fortschr Neurol Psychiatr. 2017 Sep;85(9):516-535. doi: 10.1055/s-0043-110095. Epub 2017 Aug 17. Review. German.

PMID:
28817841
22.

Autonomic Dysfunction in Parkinson's Disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms.

Jost WH.

Int Rev Neurobiol. 2017;134:771-785. doi: 10.1016/bs.irn.2017.04.003. Epub 2017 Jun 1. Review.

PMID:
28805582
23.

Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics.

Francisco GE, Bandari DS, Bavikatte G, Jost WH, Adams AM, Largent J, Esquenazi A.

J Rehabil Med. 2017 Aug 31;49(8):659-666. doi: 10.2340/16501977-2245.

24.

The botulinum toxin legend of Reinhard Heydrich's death: The end of "Himmler's brain".

Tatu L, Jost W, Bogousslavsky J.

Neurology. 2017 Jul 4;89(1):84-87. doi: 10.1212/WNL.0000000000004066.

PMID:
28674156
25.

An update on the recognition and treatment of autonomic symptoms in Parkinson's disease.

Jost WH.

Expert Rev Neurother. 2017 Aug;17(8):791-799. doi: 10.1080/14737175.2017.1345307. Epub 2017 Jun 28. Review.

PMID:
28631489
26.

[Nonmotor symptoms in Parkinson's disease].

Jost WH.

Nervenarzt. 2017 Aug;88(8):874-887. doi: 10.1007/s00115-017-0346-7. Review. German.

PMID:
28484821
27.

[King's Parkinson's disease pain scale : Intercultural adaptation in the German language].

Jost WH, Rizos A, Odin P, Löhle M, Storch A.

Nervenarzt. 2018 Feb;89(2):178-183. doi: 10.1007/s00115-017-0333-z. German.

PMID:
28444406
28.

[Therapy of Hemifacial Spasm with Botulinum Toxin].

Jost WH, Laskawi R, Palmowski-Wolfe A, Urban PP.

Fortschr Neurol Psychiatr. 2017 Apr;85(4):194-198. doi: 10.1055/s-0043-104698. Epub 2017 Apr 24. Review. German.

PMID:
28437820
29.

[Pharmacological treatment of motor symptoms in Parkinson's diseases].

Jost WH.

Nervenarzt. 2017 Apr;88(4):373-382. doi: 10.1007/s00115-017-0309-z. Review. German.

PMID:
28289795
30.

Differentiation of atypical Parkinson syndromes.

Höglinger GU, Kassubek J, Csoti I, Ehret R, Herbst H, Wellach I, Winkler J, Jost WH.

J Neural Transm (Vienna). 2017 Aug;124(8):997-1004. doi: 10.1007/s00702-017-1700-4. Epub 2017 Feb 27. Review.

PMID:
28243754
31.

Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson's Disease.

Ossig C, Sippel D, Fauser M, Gandor F, Jost WH, Ebersbach G, Storch A.

J Parkinsons Dis. 2017;7(2):325-330. doi: 10.3233/JPD-160996.

PMID:
28222537
32.

How Do I Treat Cervical Dystonia With Botulinum Toxin by Using Ultrasound?

Jost WH.

Mov Disord Clin Pract. 2017 Feb 8;4(4):647. doi: 10.1002/mdc3.12468. eCollection 2017 Jul-Aug.

33.

"An essay on the shaking palsy" 200 years old.

Jost WH, Reichmann H.

J Neural Transm (Vienna). 2017 Aug;124(8):899-900. doi: 10.1007/s00702-017-1684-0. No abstract available.

PMID:
28155132
34.

Autonomic disturbances including impaired hand thermoregulation in multiple system atrophy and Parkinson's disease.

Augustis S, Saferis V, Jost WH.

J Neural Transm (Vienna). 2017 Aug;124(8):965-972. doi: 10.1007/s00702-016-1665-8. Epub 2016 Dec 21.

PMID:
28004201
35.

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R.

JAMA Neurol. 2017 Feb 1;74(2):216-224. doi: 10.1001/jamaneurol.2016.4467.

PMID:
27942720
36.

Poster 361 Impact of Early Intervention with OnabotulinumtoxinA Treatment in Adult Patients with Post-Stroke Lower Limb Spasticity.

Patel AT, Ward AB, Geis C, Liu C, Jost WH, Dimitrova R.

PM R. 2016 Sep;8(9S):S279. doi: 10.1016/j.pmrj.2016.07.289. Epub 2016 Sep 24. No abstract available.

PMID:
27673114
37.

Poster 281 The Adult Spasticity International Registry (ASPIRE Study): Baseline Demographics and Clinical Characteristics of Patients Treated for Spasticity.

Francisco GE, Bandari D, Bavikatte G, Jost WH, Adams AM, Largent J, Esquenazi A.

PM R. 2016 Sep;8(9S):S251-S252. doi: 10.1016/j.pmrj.2016.07.454. Epub 2016 Sep 24. No abstract available.

PMID:
27673038
38.

Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.

Poewe W, Burbaud P, Castelnovo G, Jost WH, Ceballos-Baumann AO, Banach M, Potulska-Chromik A, Ferreira JJ, Bihari K, Ehler E, Bares M, Dzyak LA, Belova AN, Pham E, Liu WJ, Picaut P.

Mov Disord. 2016 Nov;31(11):1649-1657. doi: 10.1002/mds.26760. Epub 2016 Sep 21.

PMID:
27653448
39.

Anatomy and cervical dystonia : "Dysfunction follows form".

Tatu L, Jost WH.

J Neural Transm (Vienna). 2017 Feb;124(2):237-243. doi: 10.1007/s00702-016-1621-7. Epub 2016 Sep 13. Review.

PMID:
27624726
40.

[Complexity of Parkinson Syndrome].

Jost W, Reichmann H.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S1-2. doi: 10.1055/s-0042-100725. Epub 2016 Aug 15. German. No abstract available.

PMID:
27525384
41.

[Practical Use of the Levodopa Pump].

Südmeyer M, Ebersbach G, Holtmann M, Jost W, Odin P, Schrader C, Winkler C.

Fortschr Neurol Psychiatr. 2016 Jul;84(7):404-10. doi: 10.1055/s-0042-104503. Epub 2016 Jul 29. Review. German.

PMID:
27471998
42.

[Parkinson's Disease at the Border Between Inpatient and Outpatient Care].

Buhmann C, Bass H, Hahne M, Jost W, Redecker C, Schwarz M, Woitalla D.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S36-40. doi: 10.1055/s-0042-103325. Epub 2016 Jun 8. Review. German.

PMID:
27276071
43.

Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's disease.

Ossig C, Sippel D, Fauser M, Gandor F, Jost WH, Ebersbach G, Storch A.

J Parkinsons Dis. 2016 May 31;6(3):597-607. doi: 10.3233/JPD-150764.

PMID:
27258695
44.

[Intercultural adaptation of the AIMS in German language: A scale for abnormal involuntary movements].

Buhmann C, Rizos A, Emmans D, Jost WH.

Nervenarzt. 2016 Apr;87(4):411-7. doi: 10.1007/s00115-016-0099-8. German.

PMID:
27023843
45.

Preface.

Reichmann H, Jost W.

J Neural Transm (Vienna). 2016 Jan;123(1):1-2. doi: 10.1007/s00702-015-1499-9. No abstract available.

PMID:
26724924
46.

Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.

Fauser M, Löhle M, Ebersbach G, Odin P, Fuchs G, Jost WH, Chaudhuri KR, Koch R; NoMoFlu-PD study group, Storch A.

J Parkinsons Dis. 2015;5(4):737-41. doi: 10.3233/JPD-150656.

PMID:
26639660
47.

Parkinson's disease between internal medicine and neurology.

Csoti I, Jost WH, Reichmann H.

J Neural Transm (Vienna). 2016 Jan;123(1):3-17. doi: 10.1007/s00702-015-1443-z. Epub 2015 Aug 23. Review.

48.

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group, Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x. Epub 2015 Aug 12.

PMID:
26264174
49.

Advanced stages of PD: interventional therapies and related patient-centered care.

Krüger R, Hilker R, Winkler C, Lorrain M, Hahne M, Redecker C, Lingor P, Jost WH.

J Neural Transm (Vienna). 2016 Jan;123(1):31-43. doi: 10.1007/s00702-015-1418-0. Epub 2015 Jul 3. Review.

PMID:
26138439
50.

The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.

Jost WH.

J Neural Transm (Vienna). 2016 Jan;123(1):51-5. doi: 10.1007/s00702-015-1416-2. Epub 2015 Jul 3. Review.

PMID:
26138438

Supplemental Content

Support Center